APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Kit

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Kit Industry Growth and Trends Forecast to 2032

4 July 2026109 pages

Choose your research edition.

Industry ResearchCancer Kit Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Kit Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Cancer Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Kit Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Kit Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cancer Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Kit is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Kit include Xiamen Biotime Biotechnology Co., Ltd., Zecen Biotech Co., Ltd, Jiangsu Macro & Micro-Test Med-Tech Co., Ltd., YHLO, Tianlong, QIAGEN, Medcaptain, Kolplast and Jiangsu Mole Bioscience Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Kit market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Kit market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Kit market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Kit.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cancer Kit market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Kit Market by Company

Xiamen Biotime Biotechnology Co., Ltd.

Zecen Biotech Co., Ltd

Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.

YHLO

Tianlong

QIAGEN

Medcaptain

Kolplast

Jiangsu Mole Bioscience Co., Ltd.

GenomeMe Lab Inc.

Fujirebio

Eurogentec

BioVendor

Biogenix Inc. Pvt. Ltd.

Cancer Kit Segment by Type

Tumor

Cancer

Cancer Kit Segment by Application

Medical

Research

Cancer Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Kit manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cancer Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tumor Table 2. Major Company of Cancer Table 3. Global Cancer Kit Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cancer Kit Sales by Type (2021-2026) & (k units) Table 5. Global Cancer Kit Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cancer Kit Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cancer Kit Sales Market Share in Value by Type (2021-2026) Table 8. Global Cancer Kit Price by Type (2021-2026) & (USD/unit) Table 9. Global Cancer Kit Sales by Type (2027-2032) & (k units) Table 10. Global Cancer Kit Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cancer Kit Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cancer Kit Sales Market Share in Value by Type (2027-2032) Table 13. Global Cancer Kit Price by Type (2027-2032) & (USD/unit) Table 14. North America Cancer Kit Sales by Type (2021-2026) & (k units) Table 15. North America Cancer Kit Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cancer Kit Sales by Type (2021-2026) & (k units) Table 17. Europe Cancer Kit Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cancer Kit Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Cancer Kit Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cancer Kit Sales by Type (2021-2026) & (k units) Table 21. Latin America Cancer Kit Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cancer Kit Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Cancer Kit Sales by Type (2021-2026) & (US$ Million) Table 24. Cancer Kit Industry Trends Table 25. Cancer Kit Industry Drivers Table 26. Cancer Kit Industry Opportunities and Challenges Table 27. Cancer Kit Industry Restraints Table 28. Global Cancer Kit Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cancer Kit Revenue Market Share by Company (2021-2026) Table 30. Global Cancer Kit Sales by Company (2021-2026) & (k units) Table 31. Global Cancer Kit Sales Share by Company (2021-2026) Table 32. Global Cancer Kit Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Cancer Kit Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cancer Kit Major Company Production Sites and Headquarters Table 35. Global Cancer Kit Company, Product Type & Application Table 36. Global Cancer Kit Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cancer Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cancer Kit Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cancer Kit Sales by Region (2021-2026) & (k units) Table 41. Global Cancer Kit Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cancer Kit Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cancer Kit Sales Market Share in Value by Region (2021-2026) Table 44. Global Cancer Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Cancer Kit Sales by Region (2027-2032) & (k units) Table 46. Global Cancer Kit Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cancer Kit Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cancer Kit Sales Market Share in Value by Region (2027-2032) Table 49. Global Cancer Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Cancer Kit Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cancer Kit Sales by Application (2021-2026) & (k units) Table 52. Global Cancer Kit Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cancer Kit Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cancer Kit Sales Market Share in Value by Application (2021-2026) Table 55. Global Cancer Kit Price by Application (2021-2026) & (USD/unit) Table 56. Global Cancer Kit Sales by Application (2027-2032) & (k units) Table 57. Global Cancer Kit Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cancer Kit Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cancer Kit Sales Market Share in Value by Application (2027-2032) Table 60. Global Cancer Kit Price by Application (2027-2032) & (USD/unit) Table 61. North America Cancer Kit Sales by Application (2021-2026) & (k units) Table 62. North America Cancer Kit Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cancer Kit Sales by Application (2021-2026) & (k units) Table 64. Europe Cancer Kit Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cancer Kit Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Cancer Kit Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cancer Kit Sales by Application (2021-2026) & (k units) Table 68. Latin America Cancer Kit Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cancer Kit Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Cancer Kit Sales by Application (2021-2026) & (US$ Million) Table 71. Xiamen Biotime Biotechnology Co., Ltd. Company Information Table 72. Xiamen Biotime Biotechnology Co., Ltd. Business Overview Table 73. Xiamen Biotime Biotechnology Co., Ltd. Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Xiamen Biotime Biotechnology Co., Ltd. Cancer Kit Product Portfolio Table 75. Xiamen Biotime Biotechnology Co., Ltd. Recent Development Table 76. Zecen Biotech Co., Ltd Company Information Table 77. Zecen Biotech Co., Ltd Business Overview Table 78. Zecen Biotech Co., Ltd Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Zecen Biotech Co., Ltd Cancer Kit Product Portfolio Table 80. Zecen Biotech Co., Ltd Recent Development Table 81. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information Table 82. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Business Overview Table 83. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Kit Product Portfolio Table 85. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Development Table 86. YHLO Company Information Table 87. YHLO Business Overview Table 88. YHLO Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. YHLO Cancer Kit Product Portfolio Table 90. YHLO Recent Development Table 91. Tianlong Company Information Table 92. Tianlong Business Overview Table 93. Tianlong Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Tianlong Cancer Kit Product Portfolio Table 95. Tianlong Recent Development Table 96. QIAGEN Company Information Table 97. QIAGEN Business Overview Table 98. QIAGEN Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. QIAGEN Cancer Kit Product Portfolio Table 100. QIAGEN Recent Development Table 101. Medcaptain Company Information Table 102. Medcaptain Business Overview Table 103. Medcaptain Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Medcaptain Cancer Kit Product Portfolio Table 105. Medcaptain Recent Development Table 106. Kolplast Company Information Table 107. Kolplast Business Overview Table 108. Kolplast Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Kolplast Cancer Kit Product Portfolio Table 110. Kolplast Recent Development Table 111. Jiangsu Mole Bioscience Co., Ltd. Company Information Table 112. Jiangsu Mole Bioscience Co., Ltd. Business Overview Table 113. Jiangsu Mole Bioscience Co., Ltd. Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Jiangsu Mole Bioscience Co., Ltd. Cancer Kit Product Portfolio Table 115. Jiangsu Mole Bioscience Co., Ltd. Recent Development Table 116. GenomeMe Lab Inc. Company Information Table 117. GenomeMe Lab Inc. Business Overview Table 118. GenomeMe Lab Inc. Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. GenomeMe Lab Inc. Cancer Kit Product Portfolio Table 120. GenomeMe Lab Inc. Recent Development Table 121. Fujirebio Company Information Table 122. Fujirebio Business Overview Table 123. Fujirebio Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Fujirebio Cancer Kit Product Portfolio Table 125. Fujirebio Recent Development Table 126. Eurogentec Company Information Table 127. Eurogentec Business Overview Table 128. Eurogentec Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Eurogentec Cancer Kit Product Portfolio Table 130. Eurogentec Recent Development Table 131. BioVendor Company Information Table 132. BioVendor Business Overview Table 133. BioVendor Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. BioVendor Cancer Kit Product Portfolio Table 135. BioVendor Recent Development Table 136. Biogenix Inc. Pvt. Ltd. Company Information Table 137. Biogenix Inc. Pvt. Ltd. Business Overview Table 138. Biogenix Inc. Pvt. Ltd. Cancer Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Biogenix Inc. Pvt. Ltd. Cancer Kit Product Portfolio Table 140. Biogenix Inc. Pvt. Ltd. Recent Development Table 141. North America Cancer Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Cancer Kit Sales by Country (2021-2026) & (k units) Table 143. North America Cancer Kit Sales Market Share by Country (2021-2026) Table 144. North America Cancer Kit Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Cancer Kit Sales Market Share Forecast by Country (2027-2032) Table 146. North America Cancer Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Cancer Kit Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Cancer Kit Market Share by Country (2021-2026) Table 149. North America Cancer Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Cancer Kit Market Share Forecast by Country (2027-2032) Table 151. Europe Cancer Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Cancer Kit Sales by Country (2021-2026) & (k units) Table 153. Europe Cancer Kit Sales Market Share by Country (2021-2026) Table 154. Europe Cancer Kit Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Cancer Kit Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Cancer Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Cancer Kit Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Cancer Kit Market Share by Country (2021-2026) Table 159. Europe Cancer Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Cancer Kit Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Cancer Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Cancer Kit Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Cancer Kit Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Cancer Kit Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Cancer Kit Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Cancer Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Cancer Kit Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Cancer Kit Market Share by Country (2021-2026) Table 169. Asia-Pacific Cancer Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Cancer Kit Market Share Forecast by Country (2027-2032) Table 171. Latin America Cancer Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Cancer Kit Sales by Country (2021-2026) & (k units) Table 173. Latin America Cancer Kit Sales Market Share by Country (2021-2026) Table 174. Latin America Cancer Kit Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Cancer Kit Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Cancer Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Cancer Kit Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Cancer Kit Market Share by Country (2021-2026) Table 179. Latin America Cancer Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Cancer Kit Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Cancer Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Cancer Kit Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Cancer Kit Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Cancer Kit Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Cancer Kit Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Cancer Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Cancer Kit Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Cancer Kit Market Share by Country (2021-2026) Table 189. Middle East and Africa Cancer Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Cancer Kit Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Cancer Kit Distributors List Table 194. Cancer Kit Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Cancer Kit Image Figure 2. Global Cancer Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Kit Sales (2021-2032) & (k units) Figure 5. Tumor Image Figure 6. Global Tumor Sales YoY Growth (2021-2032) & (k units) Figure 7. Cancer Image Figure 8. Global Cancer Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Cancer Kit Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cancer Kit Market Share by Type 2025 VS 2032 Figure 11. North America Cancer Kit Sales Market Share in Volume by Type in 2025 Figure 12. North America Cancer Kit Sales Market Share in Value by Type in 2025 Figure 13. Europe Cancer Kit Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cancer Kit Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cancer Kit Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cancer Kit Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cancer Kit Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cancer Kit Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cancer Kit Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cancer Kit Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cancer Kit Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medical Image Figure 24. Global Medical Sales YoY Growth (2021-2032) & (k units) Figure 25. Research Image Figure 26. Global Research Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Cancer Kit Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cancer Kit Market Share by Application 2025 VS 2032 Figure 29. North America Cancer Kit Sales Market Share in Volume by Application in 2025 Figure 30. North America Cancer Kit Sales Market Share in Value by Application in 2025 Figure 31. Europe Cancer Kit Sales Market Share in Volume by Application in 2025 Figure 32. Europe Cancer Kit Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Cancer Kit Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Cancer Kit Sales Market Share in Value by Application in 2025 Figure 35. Latin America Cancer Kit Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Cancer Kit Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Cancer Kit Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Cancer Kit Sales Market Share in Value by Application in 2025 Figure 39. North America Cancer Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Cancer Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Cancer Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Cancer Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cancer Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Cancer Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cancer Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Cancer Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Cancer Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Cancer Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cancer Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Cancer Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Cancer Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Cancer Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cancer Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cancer Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Cancer Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Cancer Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cancer Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Cancer Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Cancer Kit Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Cancer Kit Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tumor
  • Cancer
Applications
  • Medical
  • Research
Companies covered
  • Xiamen Biotime Biotechnology Co., Ltd.
  • Zecen Biotech Co., Ltd
  • Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
  • YHLO
  • Tianlong
  • QIAGEN
  • Medcaptain
  • Kolplast
  • Jiangsu Mole Bioscience Co., Ltd.
  • GenomeMe Lab Inc.
  • Fujirebio
  • Eurogentec
  • BioVendor
  • Biogenix Inc. Pvt. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cancer Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cancer Kit Market by Type
  6. 1.3.1 Tumor
  7. 1.3.2 Cancer
  8. 1.4 Global Cancer Kit Market Size by Type
  9. 1.4.1 Global Cancer Kit Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cancer Kit Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cancer Kit Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cancer Kit Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cancer Kit Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cancer Kit Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cancer Kit Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cancer Kit Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cancer Kit Industry Trends
  2. 2.2 Cancer Kit Industry Drivers
  3. 2.3 Cancer Kit Industry Opportunities and Challenges
  4. 2.4 Cancer Kit Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cancer Kit Revenue (2021-2026)
  2. 3.2 Global Top Players by Cancer Kit Sales (2021-2026)
  3. 3.3 Global Top Players by Cancer Kit Price (2021-2026)
  4. 3.4 Global Cancer Kit Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Kit Major Company Production Sites & Headquarters
  6. 3.6 Global Cancer Kit Company, Product Type & Application
  7. 3.7 Global Cancer Kit Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Kit Tier 1, Tier 2, and Tier 3
4 Cancer Kit Regional Status and Outlook
  1. 4.1 Global Cancer Kit Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cancer Kit Historic Market Size by Region
  3. 4.2.1 Global Cancer Kit Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cancer Kit Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cancer Kit Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cancer Kit Forecasted Market Size by Region
  7. 4.3.1 Global Cancer Kit Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cancer Kit Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cancer Kit Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cancer Kit by Application
  1. 5.1 Cancer Kit Market by Application
  2. 5.1.1 Medical
  3. 5.1.2 Research
  4. 5.2 Global Cancer Kit Market Size by Application
  5. 5.2.1 Global Cancer Kit Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cancer Kit Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cancer Kit Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cancer Kit Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cancer Kit Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cancer Kit Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cancer Kit Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cancer Kit Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xiamen Biotime Biotechnology Co., Ltd.
  2. 6.1.1 Xiamen Biotime Biotechnology Co., Ltd. Company Information
  3. 6.1.2 Xiamen Biotime Biotechnology Co., Ltd. Business Overview
  4. 6.1.3 Xiamen Biotime Biotechnology Co., Ltd. Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xiamen Biotime Biotechnology Co., Ltd. Cancer Kit Product Portfolio
  6. 6.1.5 Xiamen Biotime Biotechnology Co., Ltd. Recent Developments
  7. 6.2 Zecen Biotech Co., Ltd
  8. 6.2.1 Zecen Biotech Co., Ltd Company Information
  9. 6.2.2 Zecen Biotech Co., Ltd Business Overview
  10. 6.2.3 Zecen Biotech Co., Ltd Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zecen Biotech Co., Ltd Cancer Kit Product Portfolio
  12. 6.2.5 Zecen Biotech Co., Ltd Recent Developments
  13. 6.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
  14. 6.3.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
  15. 6.3.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Business Overview
  16. 6.3.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Kit Product Portfolio
  18. 6.3.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments
  19. 6.4 YHLO
  20. 6.4.1 YHLO Company Information
  21. 6.4.2 YHLO Business Overview
  22. 6.4.3 YHLO Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 YHLO Cancer Kit Product Portfolio
  24. 6.4.5 YHLO Recent Developments
  25. 6.5 Tianlong
  26. 6.5.1 Tianlong Company Information
  27. 6.5.2 Tianlong Business Overview
  28. 6.5.3 Tianlong Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tianlong Cancer Kit Product Portfolio
  30. 6.5.5 Tianlong Recent Developments
  31. 6.6 QIAGEN
  32. 6.6.1 QIAGEN Company Information
  33. 6.6.2 QIAGEN Business Overview
  34. 6.6.3 QIAGEN Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 QIAGEN Cancer Kit Product Portfolio
  36. 6.6.5 QIAGEN Recent Developments
  37. 6.7 Medcaptain
  38. 6.7.1 Medcaptain Company Information
  39. 6.7.2 Medcaptain Business Overview
  40. 6.7.3 Medcaptain Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Medcaptain Cancer Kit Product Portfolio
  42. 6.7.5 Medcaptain Recent Developments
  43. 6.8 Kolplast
  44. 6.8.1 Kolplast Company Information
  45. 6.8.2 Kolplast Business Overview
  46. 6.8.3 Kolplast Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kolplast Cancer Kit Product Portfolio
  48. 6.8.5 Kolplast Recent Developments
  49. 6.9 Jiangsu Mole Bioscience Co., Ltd.
  50. 6.9.1 Jiangsu Mole Bioscience Co., Ltd. Company Information
  51. 6.9.2 Jiangsu Mole Bioscience Co., Ltd. Business Overview
  52. 6.9.3 Jiangsu Mole Bioscience Co., Ltd. Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Mole Bioscience Co., Ltd. Cancer Kit Product Portfolio
  54. 6.9.5 Jiangsu Mole Bioscience Co., Ltd. Recent Developments
  55. 6.10 GenomeMe Lab Inc.
  56. 6.10.1 GenomeMe Lab Inc. Company Information
  57. 6.10.2 GenomeMe Lab Inc. Business Overview
  58. 6.10.3 GenomeMe Lab Inc. Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GenomeMe Lab Inc. Cancer Kit Product Portfolio
  60. 6.10.5 GenomeMe Lab Inc. Recent Developments
  61. 6.11 Fujirebio
  62. 6.11.1 Fujirebio Company Information
  63. 6.11.2 Fujirebio Business Overview
  64. 6.11.3 Fujirebio Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fujirebio Cancer Kit Product Portfolio
  66. 6.11.5 Fujirebio Recent Developments
  67. 6.12 Eurogentec
  68. 6.12.1 Eurogentec Company Information
  69. 6.12.2 Eurogentec Business Overview
  70. 6.12.3 Eurogentec Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Eurogentec Cancer Kit Product Portfolio
  72. 6.12.5 Eurogentec Recent Developments
  73. 6.13 BioVendor
  74. 6.13.1 BioVendor Company Information
  75. 6.13.2 BioVendor Business Overview
  76. 6.13.3 BioVendor Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BioVendor Cancer Kit Product Portfolio
  78. 6.13.5 BioVendor Recent Developments
  79. 6.14 Biogenix Inc. Pvt. Ltd.
  80. 6.14.1 Biogenix Inc. Pvt. Ltd. Company Information
  81. 6.14.2 Biogenix Inc. Pvt. Ltd. Business Overview
  82. 6.14.3 Biogenix Inc. Pvt. Ltd. Cancer Kit Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biogenix Inc. Pvt. Ltd. Cancer Kit Product Portfolio
  84. 6.14.5 Biogenix Inc. Pvt. Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Cancer Kit Sales by Country
  2. 7.1.1 North America Cancer Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cancer Kit Sales by Country (2021-2026)
  4. 7.1.3 North America Cancer Kit Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cancer Kit Market Size by Country
  6. 7.2.1 North America Cancer Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cancer Kit Market Size by Country (2021-2026)
  8. 7.2.3 North America Cancer Kit Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cancer Kit Sales by Country
  2. 8.1.1 Europe Cancer Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cancer Kit Sales by Country (2021-2026)
  4. 8.1.3 Europe Cancer Kit Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cancer Kit Market Size by Country
  6. 8.2.1 Europe Cancer Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cancer Kit Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cancer Kit Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cancer Kit Sales by Country
  2. 9.1.1 Asia-Pacific Cancer Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cancer Kit Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cancer Kit Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cancer Kit Market Size by Country
  6. 9.2.1 Asia-Pacific Cancer Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cancer Kit Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cancer Kit Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cancer Kit Sales by Country
  2. 10.1.1 South America Cancer Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cancer Kit Sales by Country (2021-2026)
  4. 10.1.3 South America Cancer Kit Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cancer Kit Market Size by Country
  6. 10.2.1 South America Cancer Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cancer Kit Market Size by Country (2021-2026)
  8. 10.2.3 South America Cancer Kit Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cancer Kit Sales by Country
  2. 11.1.1 Middle East and Africa Cancer Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cancer Kit Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cancer Kit Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cancer Kit Market Size by Country
  6. 11.2.1 Middle East and Africa Cancer Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cancer Kit Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cancer Kit Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cancer Kit Value Chain Analysis
  2. 12.1.1 Cancer Kit Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cancer Kit Production Mode & Process
  7. 12.2 Cancer Kit Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cancer Kit Distributors
  10. 12.2.3 Cancer Kit Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst